ECS Botanics Ltd (ASX:ECS) managing director Nan-Maree Schoerie tells Proactive the company is an Australian medicinal cannabis cultivator and manufacturer with operations in northwest Victoria.
ECS Botanics (ECS) has reported significant growth in its December quarter, achieving its key milestone of positive quarterly cashflow.
ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…
Having a regulatory compliance expert for a husband may have kick-started her cannabis career, but Nan-Maree Schoerie is ploughing her own path in the industry. In the first of a two-part interview with Cannabiz, she tells of the early days of Murray Meds and explains why greenhouse growing is no longer sustainable in Australia. Sometimes in…
The country’s next coalition government plans to keep cannabis tightly regulated, party representatives said. Recreational use of cannabis is only legal in two other EU countries. Germany’s future coalition of the Social Democrats (SPD), Green party, and Free Democrats (FDP), have signalled that they are seriously considering legalizing the possession of cannabis. Representatives from the parties told…
Australian cannabis companies are standing out as making a cautious yet steady entry into the cannabis industry. One of these companies is ECS Botanics. “ECS Botanics started as a hemp company,” says Alex Keach, founder, and Managing Director of ECS Botanics. “We have a farm in Tasmania where we grow our cannabis outdoors.” The idea…
Dear shareholders, FY21 has been a defining year for the company as we start to leverage assets that we have established in proceeding years. These include our production base, industry leading team and culture, intellectual property and systems. As a result, the company is at a major inflection point. We are now in a position…
Noosa is set to become the home of one of four new medicinal cannabis clinics and three dispensaries providing support for patients from the Brisbane region through to the Sunshine Coast. Releaf Clinics are set to open in Caloundra, Noosa, Mooloolaba and Fortitude Valley over the next four months with Caloundra slated to open first…
Managing Director, Alex Keach breaks down the demand dynamics for medicinal cannabis & GMP complaint products, as ECS Botanics Holdings looks to execute on a global market opportunity. After a multi-year period of development, the pieces are now in place for Australia to become a global leader in the production, sale and export of medicinal cannabis, ECS Botanics’ Managing…
Australia has the potential to become the international gold standard for production of medicinal marijuana and multiple ASX-listed companies are seeking to benefit. – Is medical marijuana legal in Australia: Manufacturing of medicinal cannabis products has been legal in Australia since 2016-Australian revenue from medicinal cannabis projected to double in 2021 to $200m-Australia has the potential…
Hype around the de-scheduling of low dose medicinal cannabis from a Schedule 4 to an over-the-counter Schedule 3 drug but added that steps needed to be taken before such a drug hits the market
Researchers in the US have started what is the country’s first double-blind, randomized, placebo-controlled study examining the effect of cannabis products on severe migraine symptoms.
A new University of Adelaide trial will explore the use of personalised medicinal cannabis dosing to prevent common and impactful symptoms of treatment in advanced cancer thanks to Federal Government funding of $1.5 million
From May 1, Australians living with a rare form of epilepsy will have access to a medicinal cannabis medicine.
